Noninvasive tests show improvements in several relevant markers in patients with metabolic dysfunction-associated steatohepatitis treated with semaglutide for 72 weeks.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/noninvasive-tests-may-track-semaglutide-response-mash-2025a1000rah?src=rss
Author :
Publish date : 2025-10-09 17:44:00
Copyright for syndicated content belongs to the linked Source.